IS8500A - 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni - Google Patents

7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni

Info

Publication number
IS8500A
IS8500A IS8500A IS8500A IS8500A IS 8500 A IS8500 A IS 8500A IS 8500 A IS8500 A IS 8500A IS 8500 A IS8500 A IS 8500A IS 8500 A IS8500 A IS 8500A
Authority
IS
Iceland
Prior art keywords
chlorobenzyloxy
benzenesulfonyl
tosylate
tetrahydro
methoxy
Prior art date
Application number
IS8500A
Other languages
English (en)
Icelandic (is)
Inventor
Clapham David
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IS8500A publication Critical patent/IS8500A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IS8500A 2003-11-28 2006-06-08 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni IS8500A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds
PCT/EP2004/013416 WO2005051916A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics

Publications (1)

Publication Number Publication Date
IS8500A true IS8500A (is) 2006-06-08

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8500A IS8500A (is) 2003-11-28 2006-06-08 7-[4-(4-klórbensýloxý)bensensúlfónýl]-8-metoxý-3-metýl-2,3,4,5-tetrahýdró-1H-3-bensasepíníummaleat eða tósýlat sem sefandi efni

Country Status (18)

Country Link
US (1) US20070275948A1 (cg-RX-API-DMAC7.html)
EP (1) EP1687279A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007512285A (cg-RX-API-DMAC7.html)
KR (1) KR20060103322A (cg-RX-API-DMAC7.html)
CN (1) CN1906170A (cg-RX-API-DMAC7.html)
AR (1) AR046719A1 (cg-RX-API-DMAC7.html)
AU (1) AU2004293179A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0417029A (cg-RX-API-DMAC7.html)
CA (1) CA2547444A1 (cg-RX-API-DMAC7.html)
GB (1) GB0327740D0 (cg-RX-API-DMAC7.html)
IL (1) IL175663A0 (cg-RX-API-DMAC7.html)
IS (1) IS8500A (cg-RX-API-DMAC7.html)
MA (1) MA28177A1 (cg-RX-API-DMAC7.html)
NO (1) NO20062970L (cg-RX-API-DMAC7.html)
RU (1) RU2006122959A (cg-RX-API-DMAC7.html)
TW (1) TW200528433A (cg-RX-API-DMAC7.html)
WO (1) WO2005051916A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603781B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2240466B1 (en) * 2008-01-08 2015-07-29 Merck Sharp & Dohme Limited Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
US20180228811A1 (en) * 2014-12-12 2018-08-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
US12297184B2 (en) 2018-10-03 2025-05-13 Tesaro, Inc. Niraparib salts
CN116406268A (zh) * 2020-10-27 2023-07-07 特维娜有限公司 δ-阿片样物质调节剂的结晶和无定形形式
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1456178A1 (en) * 2001-12-21 2004-09-15 Smithkline Beecham Plc 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
PL371344A1 (en) * 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents
MY133587A (en) * 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use

Also Published As

Publication number Publication date
WO2005051916A1 (en) 2005-06-09
CN1906170A (zh) 2007-01-31
US20070275948A1 (en) 2007-11-29
EP1687279A1 (en) 2006-08-09
JP2007512285A (ja) 2007-05-17
TW200528433A (en) 2005-09-01
AR046719A1 (es) 2005-12-21
ZA200603781B (en) 2007-09-26
MA28177A1 (fr) 2006-09-01
AU2004293179A1 (en) 2005-06-09
IL175663A0 (en) 2006-09-05
CA2547444A1 (en) 2005-06-09
RU2006122959A (ru) 2008-01-10
GB0327740D0 (en) 2003-12-31
BRPI0417029A (pt) 2007-02-06
NO20062970L (no) 2006-08-21
KR20060103322A (ko) 2006-09-28

Similar Documents

Publication Publication Date Title
IS7314A (is) 5,6-díarýl-pýrasín-2-amíðafleiður sem cb1 mótlyf
IL168102A0 (en) Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
IL177798A0 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
IL183706A0 (en) 2,4(4,6) pyrimidine derivatives
NO20023485L (no) 1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister
PT1381363E (pt) Derivados de imidazo-(1,2-a)-piridina como antagonistas mglur5
NO20034439L (no) Benzamidinderivater
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20034338L (no) Ekspanderbart verktöy nede i brönnen
IS7088A (is) Nýjar afleiður oxasólidínóna sem bakteríueyðandi lyf
IS7388A (is) Bensensúlfónamíðafleiður sem sefandi efni
BR0300119B1 (pt) composiÇço aquosa.
NO20051956D0 (no) Salmeterol superfin formulering
PT1514871E (pt) Diespiro 1,2,4-trioxolanos contra a malária
ZA200603781B (en) 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium maleate or tosylate as antipsychotics
FI20020881A0 (fi) Iskulaite
IS7488A (is) Dreyfasamsetning í föstu formi
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
EP1610795A4 (en) HETEROCYCLIC SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE ANALOGUE
DE602004010148D1 (de) Schaumdüse
MXPA03006648A (es) Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.
IL182314A0 (en) 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
DK1651607T3 (da) 6-(1,1-difluoralkyl)-4-aminopicolinater og deres anvendelse som herbicider
IL173004A0 (en) Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments